Press Releases

13 Aug 2024

Singapore Researchers Discover New Candida auris – A Possible Global Public Health Threat

Researchers from the Singapore General Hospital (SGH), A*STAR’s Genome Institute of Singapore (GIS) and Yong Loo Lin School of Medicine at National University of Singapore (NUS Medicine) have discovered a new clade (or type) of Candida auris, bringing the number of clades known globally to a total of six.

05 Aug 2024

Significant discrepancies between actual and labelled amount of anti-ageing ingredients in supplements: NUS Medicine study

How do we know if the supplements we consume are giving us the right amount of ingredients as stated on their labels at the point of sale? Many of these anti-ageing (also called geroprotector) ingredients such as Nicotinamide Mononucleotide (NMN) and Urolithin A are included to promote cell repair and improve muscle function and strength.

31 Jul 2024

Clinical ageing clocks: NUS and SGH develop algorithm-powered tests to indicate mortality risk

A few tubes of blood, a urine test and a health questionnaire to determine a person’s biological age are all that is needed to indicate one’s future risk of mortality. A new class of clinical ageing clocks using these tests has emerged – PCAge and LinAge – which outline the healthy and unhealthy ageing trajectories and provide a new way to test ageing intervention strategies.

22 Jul 2024

Boosting fruit intake during midlife can ward off late-life blues: NUS study

In a large Singapore cohort study involving over 13,000 participants spanning close to 20 years, higher consumption of fruits during midlife was found to be associated with lower odds of depressive symptoms at late-life

17 Jul 2024

New research reveals link between spinal muscular atrophy (SMA) and liver damage.

An international study has discovered that people living with the neurodegenerative condition Spinal Muscular Atrophy (SMA) are at higher risk of developing fatty liver disease, suggesting that SMA patients may face additional health problems over time. This finding raises significant concerns about long-term care and health outcomes for individuals with SMA.

01 Jul 2024

NUS Medicine and 22Health Ventures announce joint healthtech accelerator

The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), and 22Health Ventures, an early-stage healthtech investment firm (22Health), announced their joint accelerator programme, NUS Medicine Digital Advanced Technology Accelerator (DATA), an NUS Medicine – 22Health Ventures partnership (the Accelerator).

19 Jun 2024

Using digital technology and data to sustain intermittent fasting and improve health outcomes: one man’s journey

A researcher from the National University of Singapore was the subject of his own digital health study, in which he embarked on a 7-month journey of 20-hour fasts coupled with a fitness regimen and clean eating.

13 Jun 2024

Neural balance in the brain is associated with brain maturity and better cognitive ability: National University of Singapore study

In a world where external and internal stimuli can throw our entire body system off balance, how does our brain prevent itself from becoming overly stimulated?

06 Jun 2024

NUS Medicine researchers engineer bacteria for targeted chemotherapy delivery

NUS Medicine researchers have identified a new method for delivering chemotherapy drugs directly to tumour sites by utilising the natural interactions between bacteria and cancer cells.

04 Jun 2024

A promising vaccine approach to induce longer-lasting protective immunity against COVID-19: NUS Medicine-Monash University study

A scientific team from the Yong Loo Lin School of Medicine at the National University of Singapore (NUS Medicine) and Monash University, Australia, has engineered a COVID-19 vaccine that induced – in pre-clinical models – very long-lasting, protective immunity against SARS-CoV-2 virus with a single-shot immunisation.